JPRN-UMIN000007465
Not yet recruiting
未知
Intravitreal Bevaxizumab injection for intraocular neovasculalization in children - Bevacizumab therapy for retinopathy of prematurity
Conditionsretinopathy of prematurity
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- retinopathy of prematurity
- Sponsor
- Tokushima university hospital
- Enrollment
- 10
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •subjects with systemic risk factors
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Intravitreal bevacizumab injection for intraocular neovascularization in childreRetinopathy of prematurityJPRN-UMIN000014316Kansai Medical University15
Completed
Not Applicable
The intravitreal injection of Bevacizumab for retinopathy of prematurityretinopathy of prematurityJPRN-UMIN000028770Department of Ophthalmology, Shiga University of Medical Science24
Not yet recruiting
Phase 2
Role of subconjunctival injection of Bevacizumab (Anti VEGF) for Corneal Neovascularisation,after cornea TransplantHealth Condition 1: - Health Condition 2: H598- Other intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classifiedCTRI/2021/10/037416SNMedical College
Withdrawn
Phase 3
Intravitreal Bevacizumab for Inflammatory Neovascular MembranesVogt Koyanagi Harada DiseaseSerpiginous ChoroiditisMultifocal ChoroiditisNCT00407121Asociación para Evitar la Ceguera en México
Completed
Not Applicable
Intravitreal bevacizumab(Avastin) for macular edema secondary to uveitis: 1 year results of a prospective pilot studyMacular edema secondary to uveitis.Other specified retinal disordersIRCT138902113846N1Shiraz University of Medical Sciences30